Search Results - "David Mayer, A"

Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase by Aggarwal, Neil R., Beaty, Laurel E., Bennett, Tellen D., Carlson, Nichole E., Mayer, David A., Molina, Kyle C., Peers, Jennifer L., Russell, Seth, Wynia, Matthew K., Ginde, Adit A.

“…•Adult outpatients infected with Omicron BA.1 or BA.1.1 were administered sotrovimab.•Sotrovimab did not reduce hospitalization compared to all untreated…”
Get full text

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5 by Molina, Kyle C, Webb, Brandon J, Kennerley, Victoria, Beaty, Laurel E, Bennett, Tellen D, Carlson, Nichole E, Mayer, David A, Peers, Jennifer L, Russell, Seth, Wynia, Matthew K, Aggarwal, Neil R, Ginde, Adit A

“…A trial performed among unvaccinated, high-risk outpatients with COVID-19 during the delta period showed remdesivir reduced hospitalization. We used our…”
Get full text

Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5 by Molina, Kyle C., Kennerley, Victoria, Beaty, Laurel E., Bennett, Tellen D., Carlson, Nichole E., Mayer, David A., Peers, Jennifer L., Russell, Seth, Wynia, Matthew K., Aggarwal, Neil R., Ginde, Adit A.

“…•Adults with COVID-19 Omicron BA2/2.12/BA.4/5 were administered bebtelovimab.•Bebtelovimab reduced hospitalization across Omicron variant periods.•Bebtelovimab…”
Get full text

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients by Douin, David J, Wogu, Adane F, Beaty, Laurel E, Carlson, Nichole E, Bennett, Tellen D, Aggarwal, Neil R, Mayer, David A, Ong, Toan C, Russell, Seth, Steele, Jeffrey, Peers, Jennifer L, Molina, Kyle C, Wynia, Matthew K, Ginde, Adit A

“…Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical…”
Get full text

331 Reusing EHR Phenotyping Algorithms in Practice: Developing the Colorado Diabetes EHR Research Repository (CODER) by Wilson, Melissa P., Mayer, David A., Rasmussen, Luke V., Khanal, Pramod, Nuriyeva, Maryam, McRae, Michael, Raghavan, Sridharan, Wiley, Laura K.

“…OBJECTIVES/GOALS: The rates of computational phenotyping algorithm reuse across health systems are low, leading to a proliferation of algorithms for the same…”
Get full text

The role of helminth infections in carcinogenesis by Mayer, David A, Fried, Bernard

“…This review examines the significant literature on the role of helminth infections in carcinogenesis. Both parasitic infections and cancer have complex natural…”
Get more information

Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID‐19 by Wendel, Sarah K., Wogu, Adane F., Carlson, Nichole E., Beaty, Laurel, Bennett, Tellen D., Bookman, Kelly, Mayer, David A., Michael, Sean M., Molina, Kyle C., Peers, Jennifer L., Russell, Seth, Zane, Richard D., Ginde, Adit A.

“…Objectives To evaluate whether subcutaneous neutralizing monoclonal antibody (mAb) treatment given in the emergency department (ED) setting was associated with…”
Get full text

Colorectal cancer in patients with inflammatory Bowel disease after liver transplantation for primary sclerosing cholangitis by VERA, Alonso, GUNSON, Bridget K, MIRZA, Darius F, USSATOFF, Val, NIGHTINGALE, Peter, CANDINAS, Daniel, RADLEY, Simon, MAYER, A. David, BUCKELS, John A. C, MCMASTER, Paul, NEUBERGER, James

“…Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) may have an increased risk of developing colorectal cancer (CRC) after…”
Get full text

Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study by Aggarwal, Neil R, Molina, Kyle C, Beaty, Laurel E, Bennett, Tellen D, Carlson, Nichole E, Mayer, David A, Peers, Jennifer L, Russell, Seth, Wynia, Matthew K, Ginde, Adit A

“…Nirmatrelvir is a protease inhibitor with in-vitro activity against SARS-CoV-2, and ritonavir-boosted nirmatrelvir can reduce the risk of progression to severe…”
Get full text

ABO-incompatible pediatric liver transplantation in very small recipients: Birmingham's experience by Gelas, Thomas, McKiernan, Patrick J., Kelly, Deirdre A., Mayer, David A., Mirza, Darius F., Sharif, Khalid

“…Gelas T, McKiernan PJ, Kelly DA, Mayer DA, Mirza DF, Sharif K. ABO‐incompatible pediatric liver transplantation in very small recipients: Birmingham’s…”
Get full text

Is It Time to Extend Liver Acceptance Criteria for Controlled Donors After Cardiac Death? by TARICIOTTI, Laura, ROEHA, Chiara, THAMARA PR PERERA, M, GUNSON, Bridget K, BRAMHALL, Simon R, ISAAE, John, BUCKELS, John A. C, DAVID MAYER, A, MUIESAN, Paolo, MIRZA, Darius F

“…Donation after cardiac death (DCD) has reemerged as potential way to increase donor liver availability. Earlier, programs with DCD liver transplantation used…”
Get full text

Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients by Aggarwal, Neil R, Beaty, Laurel E, Bennett, Tellen D, Carlson, Nichole E, Davis, Christopher B, Kwan, Bethany M, Mayer, David A, Ong, Toan C, Russell, Seth, Steele, Jeffrey, Wogu, Adane F, Wynia, Matthew K, Zane, Richard D, Ginde, Adit A

“…It is not known whether sotrovimab, a neutralizing monoclonal antibody (mAb) treatment authorized for early symptomatic coronavirus disease 2019 (COVID-19)…”
Get full text

Conventional versus piggyback technique of caval implantation; without extra-corporeal veno-venous bypass. A comparative study by Khan, Saboor, Silva, Michael A, Tan, Yu Meng, John, Abraham, Gunson, Bridget, Buckels, John A C, David Mayer, A, Bramhall, Simon R, Mirza, Darius F

“…Conventional orthotopic liver transplantation (CON-LT) involves resection of recipient cava, usually with extra-corporeal circulation (veno-venous bypass,…”
Get more information

Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-A 12-year experience by BHATTACHARJYA, Shantanu, GUNSON, Bridget K, MIRZA, Darius F, MAYER, David A, BUCKELS, John A. C, MCMASTER, Paul, NEUBERGER, James M

“…Although the clinical features of early hepatic artery thrombosis (HAT) are well defined, the features of delayed (more than 4 weeks after transplantation)…”
Get full text

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients by Wynia, Matthew K., Beaty, Laurel E., Bennett, Tellen D., Carlson, Nichole E., Davis, Christopher B., Kwan, Bethany M., Mayer, David A., Ong, Toan C., Russell, Seth, Steele, Jeffrey D., Stocker, Heather R., Wogu, Adane F., Zane, Richard D., Sokol, Ronald J., Ginde, Adit A.

“…Neutralizing monoclonal antibodies (mAbs) were authorized for the treatment of COVID-19 outpatients based on clinical trials completed early in the pandemic,…”
Get full text

Application of Portsmouth modification of physiological and operative severity scoring system for enumeration of morbidity and mortality (P-POSSUM) in pancreatic surgery by Tamijmarane, Appou, Bhati, Chandra S, Mirza, Darius F, Bramhall, Simon R, Mayer, David A, Wigmore, Stephen J, Buckels, John Ac

“…Pancreatoduodenectomy (PD) is associated with high incidence of morbidity and mortality. We have applied P-POSSUM in predicting the incidence of outcome after…”
Get full text

Arterial conduits for hepatic artery revascularisation in adult liver transplantation by Muralidharan, Vijayaragavan, Imber, Charles, Leelaudomlipi, Surasak, Gunson, Bridget K, Buckels, John A C, Mirza, Darius F, Mayer, A David, Bramhall, Simon R

“…Arterial complications after orthotopic liver transplantation (OLT), including hepatic artery thrombosis (HAT), are important causes of early graft failure…”
Get more information

Specialist Early and Immediate Repair of Post-laparoscopic Cholecystectomy Bile Duct Injuries Is Associated With an Improved Long-term Outcome by PERERA, M. Thamara P. R, SILVA, Michael A, HEGAB, Bassem, MURALIDHARAN, Vijayaragavan, BRAMHALL, Simon R, MAYER, A. David, BUCKELS, John A. C, MIRZA, Darius F

“…A majority of bile duct injuries (BDI) sustained during laparoscopic cholecystectomy require formal surgical reconstruction, and traditionally this repair is…”
Get full text

ReviewR: a light-weight and extensible tool for manual review of clinical records by Mayer, David A, Rasmussen, Luke V, Roark, Christopher D, Kahn, Michael G, Schilling, Lisa M, Wiley, Laura K

“…Manual record review is a crucial step for electronic health record (EHR)-based research, but it has poor workflows and is error prone. We sought to build a…”
Get full text

A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies by Xiao, Mengli, Molina, Kyle C, Aggarwal, Neil R, Beaty, Laurel E, Bennett, Tellen D, Carlson, Nichole E, Fish, Lindsey E, Hamer, Mika K, Kwan, Bethany M, Mayer, David A, Peers, Jennifer L, Wynia, Matthew K, Ginde, Adit A

“…During the COVID-19 pandemic, the effective distribution of limited treatments became a crucial policy goal. Yet, limited research exists using electronic…”
Get full text